Registration of in vitro diagnostic products
by Derrick Corea Technosoft Innovations, IncMedical device market is ranked second largest in the world.
Population growth is growing at about 20 percent since 2009. It is expected to
maintain this growth over the next few years. the predicted growth rate of the
global market. By 2020, China will have 400 million people who are 60 years-old
or older, and 100 million older than 80. By 2050, a third of the 1.4 billion
Chinese will be at least 60.
Medical product Designing |
Pharmaceutical Materials Association's Medical Device
Branch, the market size reach RMB300 (over $ 48) billion by 2015. The driving
factors include fast growing growth, the world's largest population, a growing
population, and population growth. The government has invested heavily in the
healthcare infrastructure and the provision of basic health insurance for all
of its citizens. Currently, there are two types of foreign-sourced products,
such as GE, Philips, and Siemens.
According to Shanghai FDA, by the end of 2013 there were a
total of 17,800 domestic medical device manufacturers and 180,000 distributing
companies. China's total sales volume was RMB 215 ($ 34.68) billion in 2013,
representing a growth of 22% since the close of fiscal year 2012. The United
States ranks # 1 in the medical market, followed by Germany and Japan. These
three countries represent the majority share of China's imports. According to
the China Chamber of Commerce for Import and Export of Medicines and Health
Products (CCCMHPIE), China's import and export value of medical equipment
reached $ 34.31 billion in 2013, an increase of 14% over 2012. 11 China has
over 16,000 hospitals, 85% of which are publicly-owned. The Chinese hospitals
consider US
At the same time, they are consolidating, upgrading quality,
and beginning to compete in medium-sized technology niches. With the government
policy to align and promote medical device innovations, some domestic
manufacturers such as Shenzhen Mindray are growing stronger and are already competing
with foreign suppliers.
Given the status of the Chinese medical device market, the
company is interested in expanding the Chinese market. On the other hand, the
new healthcare reform, qui started in 2009, is at the course of advancing the
reform on public hospitals. An accumulated investment of over RMB 2.242
trillion ($ 359 trillion) has-been Invested by the government during the last
five years to Improve the healthcare infrastructure. The reform will definitely
impact future medical device sales opportunities in China. Companies interested
in entering the marketplace. Recently, China's State Council announced changes
in the Regulation for Supervision and Administration of Medical Devices (Order
650), slated for implementation on June 1, 2014. Order 650 is the revision of
the old regulation Order 276 qui Was Implemented in 2000. As the regulator of medical
devices, China Food and Drug Administration (CFDA) is expected to issue a
number of technical documents on June 1st for this new regulation. Compared
with the old regulation, noticeable changes include the validity of the
registration certificate to five years; adopting a notification system to
replace the registration system for all Class I products; Chinese language on
the product manual, labels, and packaging labels; Required clinical trials
inside China for the Class II and Class III medical devices that are not on the
CFDA's exemption catalog. Additional issues and challenges that the US expects
will face include pricing, and bar code systems that are delaying entry into
the Chinese medical device market. Sub-Sector Best Prospects The best-selling prospects
in the medical device sector include: • In vitro diagnostic equipment and
reagents: Clinical and diagnostic analysis equipment, diagnostic reagents,
medical test and basic equipment instruments, and point of care testing (POCT).
• Implantable and speech materials and artificial organs: Interventional
materials, implantable artificial organs, artificial organs touch, stent,
implantable materials, and artificial organ Assisting equipment. medical test
and basic equipment instruments, and point of care testing (POCT). Implantable
and interventional materials and artificial organs: Interventional materials,
implantable artificial organs, artificial contact organs, stent, implantable
materials, and artificial organ assisting equipment. medical test and basic
equipment instruments, and point of care testing (POCT). Implantable and
interventional materials and artificial organs: Interventional materials,
implantable artificial organs, artificial contact organs, stent, implantable
materials, and artificial organ assisting equipment.
• Therapeutic products: Tri-dimensional ultrasound-focused
therapeutic systems, body rotational Gamma knife, simulator, linear
accelerator, laser diagnosis and surgical equipment, nuclide treatment
equipment, physical and rehabilitation equipment. 12 • Medical diagnostic and
imaging equipment: Black & white and supersonic diagnostic units, sleeping
monitor, digital X-ray system, MRI, CT, DR, and ultrasound equipment. •
Surgical and emergency appliances: Anesthesia ventilation systems and
components: high frequency surgical equipment, high frequency and voltage
generators. • Healthcare Information Technology related equipment and products:
Medical software, computer aided diagnostic equipment, and hospital information
systems (HIS, CIS, and HLT). • Medical equipment parts and accessories.
Sponsor Ads
Created on Sep 27th 2018 08:57. Viewed 377 times.